Jiewu Liu, PhD
Director, Bioanalytical Science
Jiewu Liu is the Director of Bioanalytical Science at Kriya Therapeutics. He has over 10 years of combined experience in bioanalytical assay development and validation. Previously, Dr. Liu was an associate director at Cambridge Biomedical (acquired by BioAgilytix Labs) where he built and led a team to provide bioanalytical support for drug development under GxPs. Before that, Dr. Liu served as bioanalysis manager at Enzyvant and its parent company Roivant Sciences where he was responsible for bioanalytical method development and validation. He held positions of increasing responsibility at Vascular Pharmaceuticals, Argos Therapeutics, and BioAgilytix.
Dr. Liu received his PhD in Biochemistry and Molecular Biology from the Shanghai Institute of Biochemistry and Cell Biology, and completed his postdoctoral fellowship at St. Jude Children’s Hospital and Weill Medical College of Cornell University. Dr. Liu received his master’s degree in Biochemistry from Nankai University.